Market Trends of Digital Biomanufacturing Industry
The Process Analytical Technologies Segment is Expected to Show Significant Growth During the Forecast Period
Process analytical technologies ensure quality in biopharmaceutical manufacturing by monitoring and controlling processes in real-time. It utilizes analytical tools to develop manufacturing processes accommodating material and equipment variability. By using this technology, critical process parameters (CPPs) impacting essential quality attributes (CQAs) are identified to develop analytical methods for real-time monitoring biopharmaceutical manufacturing. The increasing expansion of process analytical laboratories to optimize biomanufacturing is expected to drive the market during the forecast period.
For instance, in March 2023, the Cell and Gene Therapy Catapult (CGT Catapult) reported opening a new laboratory in Stevenage, United Kingdom. This process analytical technologies laboratory is expected to provide an analytically and digitally enabled space for cell and gene therapy developers to ensure the quality of the products is controlled and retained as they prepare to scale up production. Hence, such expansion is expected to increase the accessibility of digital biomanufacturing solutions and drive the market during the forecast period. Also, the increasing demand for the quality of biological products is expected to increase the adoption of process analytical technologies for continuous monitoring of biopharmaceutical manufacturing, which will ultimately drive the market during the forecast period.
For instance, according to an article published in the Wiley Journal in April 2022, the implementation of continuous manufacturing for biological processes producing protein-based drug molecules, such as monoclonal antibodies (mAbs), is facing several new hurdles. However, the improved process understanding through better predictive capabilities enabled by process analytical technologies is solving this problem efficiently to improve the overall production of monoclonal antibodies production. Hence, the increasing adoption of PAT to improve the overall quality of biological products is expected to drive the market during the forecast period.
North America is Expected to Hold the Largest Share of the Market During the Forecast Period
The geographical analysis of the digital biomanufacturing market shows that North America holds a significant market share in the global market. This is due to the increasing investments in the biopharmaceutical industries and the expansion of biopharmaceutical manufacturing facilities in the region.
The increasing expansion of biopharmaceutical manufacturing facilities increases the utilization of digital biomanufacturing solutions for the cost and time-efficient manufacturing of biological products, which will ultimately drive the market during the forecast period.
For instance, in March 2023, the Canadian government planned to invest CAD 80.5 million (USD 59 million) in the Canadian Critical Drug Initiative to boost drug research, commercialization, and manufacturing in the Alberta province. Applied Pharmaceutical Innovation, in partnership with the Li Ka Shing Applied Virology Institute at the University of Alberta, planned to establish a new 40,000-square-foot manufacturing facility in Edmonton with the support of this fund provided by the government. Hence, such expansion increases the adoption of digital biomanufacturing solutions, which will drive the market during the forecast period.
Also, the growing strategic activities, such as the launch of new biomanufacturing solutions, are expected to increase accessibility and drive the market during the forecast period. For instance, in April 2024, SAP SE, a business technology company, launched AI advancements in its supply chain solutions, unleashing a transformative wave of productivity, efficiency, and precision in biomanufacturing. By utilizing AI-powered analysis of up-to-the-minute data, biopharmaceutical companies may leverage their data to enhance decision-making throughout supply chains, optimize product creation, and enhance industrial efficiency. Hence, such digital solutions are expected to increase the accessibility and adoption of digital biomanufacturing solutions, further driving the market during the forecast period.
Hence, the increasing government investments and growing strategic activities are expected to drive the market during the forecast period in North America.
